COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.
In a cohort of severe asthma patients, a small number of COVID-19 cases was found; none resulted in death or a very severe disease course. Use of biologics for severe allergic or severe eosinophilic asthma was not associated with a higher risk of COVID-19.
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2020 |
Verlag/Hrsg.: |
European Respiratory Society
|
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28880038 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/238836 |